From Evidence to Rationale: Cardiovascular Protection by Angiotensin II Receptor Blockers Compared with Angiotensin-Converting Enzyme Inhibitors

Michael Böhm; Magnus Baumhäkel; Felix Mahfoud; Christian Werner

doi:10.1159/000320094

From Evidence to Rationale: Cardiovascular Protection by Angiotensin II Receptor Blockers Compared with Angiotensin-Converting Enzyme Inhibitors

Cardiology ◽

10.1159/000320094 ◽

2010 ◽

Vol 117 (3) ◽

pp. 163-173 ◽

Cited By ~ 10

Author(s):

Michael Böhm ◽

Magnus Baumhäkel ◽

Felix Mahfoud ◽

Christian Werner

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Angiotensin Ii Receptor Blockers ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Cardiovascular Protection ◽

Receptor Blockers

Download Full-text

Faculty Opinions recommendation of Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737768802.793574287 ◽

2020 ◽

Cited By ~ 1

Author(s):

Tahir Hussain

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Angiotensin Ii Receptor Blockers ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study)

The American Journal of Cardiology ◽

10.1016/j.amjcard.2021.02.009 ◽

2021 ◽

Vol 147 ◽

pp. 58-60

Author(s):

Hazrije Mustafic ◽

Abdallah Fayssoil ◽

Loïc Josseran ◽

Mounir Ouadahi ◽

Lamiae Grimaldi-Bensouda ◽

...

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Angiotensin Ii Receptor Blockers ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Hypertensive Patients ◽

Receptor Blockers

Download Full-text

Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers

Immunopharmacology and Immunotoxicology ◽

10.3109/08923973.2013.797992 ◽

2013 ◽

Vol 35 (3) ◽

pp. 447-450 ◽

Cited By ~ 10

Author(s):

Gino A. Vena ◽

Nicoletta Cassano ◽

Valeria Coco ◽

Clara De Simone

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Angiotensin Ii Receptor Blockers ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Renin–angiotensin–aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?

Acta Diabetologica ◽

10.1007/s00592-005-0179-x ◽

2005 ◽

Vol 42 (S1) ◽

pp. s33-s41 ◽

Cited By ~ 10

Author(s):

L. M. Ruilope

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Angiotensin Ii Receptor Blockers ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Renal Protection ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality

Hypertension ◽

10.1161/hypertensionaha.120.15622 ◽

2020 ◽

Vol 76 (2) ◽

Cited By ~ 14

Author(s):

Feng Zhou ◽

Ye-Mao Liu ◽

Jing Xie ◽

Haomiao Li ◽

Fang Lei ◽

...

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Angiotensin Ii Receptor Blockers ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID‐19 infection in a multi‐site UK acute hospital trust

European Journal of Heart Failure ◽

10.1002/ejhf.1924 ◽

2020 ◽

Vol 22 (6) ◽

pp. 967-974 ◽

Cited By ~ 28

Author(s):

Daniel M. Bean ◽

Zeljko Kraljevic ◽

Thomas Searle ◽

Rebecca Bendayan ◽

O'Gallagher Kevin ◽

...

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Acute Hospital ◽

Angiotensin Ii Receptor Blockers ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Re. Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19

Epidemiology ◽

10.1097/ede.0000000000001250 ◽

2020 ◽

Vol Publish Ahead of Print ◽

Cited By ~ 1

Author(s):

Julie Rouette ◽

Karine Suissa ◽

Laurent Azoulay

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Angiotensin Ii Receptor Blockers ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Receptor Blockers

Download Full-text

Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis

PLoS Computational Biology ◽

10.1371/journal.pcbi.1008235 ◽

2020 ◽

Vol 16 (10) ◽

pp. e1008235

Author(s):

Mehrshad Sadria ◽

Anita T. Layton

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Angiotensin Ii Receptor Blockers ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Modeling Analysis ◽

Receptor Blockers

Download Full-text

Therapeutic trials comparing angiotensin converting enzyme inhibitors and Angiotensin II receptor blockers

Current Hypertension Reports ◽

10.1007/s11906-000-0045-8 ◽

2000 ◽

Vol 2 (4) ◽

pp. 402-411 ◽

Cited By ~ 36

Author(s):

William J. Elliott

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Angiotensin Ii Receptor Blockers ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Therapeutic Trials ◽

Receptor Blockers

Download Full-text

Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers: Is There a Difference in Response and Any Advantage to Using Them Together in the Treatment of Hypertension?

Journal of Clinical Hypertension ◽

10.1111/j.1751-7176.2008.08560.x ◽

2008 ◽

Vol 10 (6) ◽

pp. 489-496 ◽

Cited By ~ 4

Author(s):

Marvin Moser ◽

Clive Rosendorff ◽

William B. White

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Angiotensin Ii Receptor Blockers ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Converting Enzyme Inhibitors ◽

Treatment Of Hypertension ◽

Receptor Blockers

Download Full-text